Southern Research CEO Jack Secrist Recognized for Contributions in Cancer Drug Research
13th Nov 2006, 23:49 GMT
Receives the 2006 John A. Montgomery Award in Switzerland
Southern Research CEO Jack Secrist Recognized for Contributions in Cancer Drug Research related news:
- SRI's Jack Secrist receives award in Switzerland for work on cancer drugs — Latest news from Birmingham Business Journal
- Recurrent breast cancer: Drug shows promise — The Cancer Blog
- First Berlin Releases Research Update Following Callisto Pharmaceutical's Announcement Of Initiation Of Phase II Trial In Advanced Carcinoid Cancer — Health News from Medical News Today
- Ludwig Fund donates $20 million to University of Chicago for cancer research — EurekAlert! - Chemistry, Physics and Materials Sciences
- Dendreon completes FDA filing for prostate-cancer drug — The Seattle Times: Horse racing
- Diseased gums raise risk of pancreatic cancer — Reuters: Health
- Cancer drug guidance concern — BBC News | Health | UK Edition
- Dismay over cancer drug guidance — BBC News | Latest Published Stories | UK Edition
- Ludwig Fund Gives $120 Million for Cancer Research Believed to Be Largest Single Gift by a Foundation for Cancer Research in the United States — mysan.de - Lifestyle News
- NICE rejects use of cancer drug Tarceva — Pharmaceutical Business Review Latest News
Latest news from Executive Announcements News from StratCenter.com:
- Anika Therapeutics Appoints Constance Garrison as VP of Regulatory and Clinical Affairs
- Accuro Healthcare Solutions Announces New CTO
- Streamline Health named to Forbes Magazine's List of The 200 Best Small Companies for 2006
- Zuckerman named treasurer for CHW
- MQ Assoc Announces Results for Q3 of 2006 and 9 Months Ended 9/30/2006
- KB Home CEO Leaves After Errors Found
- NanoLogix Appoints Global Auto Industry Executive as SVP
- CryoCath named to Deloitte's Technology Fast 500
- Is Your Cat Tight-Lipped When it Comes to His Health? A New Study Finds it's Time to Get Him to Open Wide!
- TMNG will review stock options, delay quarterly filing